Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
202.70
-0.90 (-0.44%)
At close: Dec 4, 2025
-4.02%
Market Cap 179.68B
Revenue (ttm) 80.13B
Net Income (ttm) 25.28B
Shares Out 886.45M
EPS (ttm) 28.52
PE Ratio 7.11
Forward PE n/a
Dividend 12.00 (5.92%)
Ex-Dividend Date Nov 17, 2025
Volume 238,667
Average Volume 356,617
Open 203.60
Previous Close 203.60
Day's Range 202.50 - 203.60
52-Week Range 198.90 - 234.10
Beta 0.11
RSI 33.08
Earnings Date Jan 29, 2026

About DSE:SQURPHARMA

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anthelmintics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 15,937
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SQURPHARMA
Full Company Profile

Financial Performance

In 2025, DSE:SQURPHARMA's revenue was 76.29 billion, an increase of 8.83% compared to the previous year's 70.10 billion. Earnings were 23.97 billion, an increase of 14.54%.

Financial Statements

News

There is no news available yet.